ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q3 2021 Results - Earnings Call Transcript

Acorda Therapeutics, Inc. (ACOR) Q3 2021 Earnings Conference Call Nov 09, 2021 04:30 PM ET Company Participants Tierney Saccavino - Executive Vice President-Corporate Communications Ron Cohen - Chief Executive Officer Mike Gesser - Chief Financial Officer Conference Call Participants Presentation Operator Good afternoon, good evening. Welcome to the Acorda Therapeutics Third Quarter 2021 Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request. I will now introduce your host for today's call Tierney Saccavino from Acorda. Please go ahead. Tierney Saccavino Thank you, Felicia, and good afternoon, everyone. Before we begin, let me remind you that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings, which are public and we encourage you to refer to those filings. As a reminder to our

For further details see:

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q3 2021 Results - Earnings Call Transcript